Acute effects of celiprolol on angiographically normal and stenotic coronary arteries

Cardiovascular Drugs and Therapy

Volumn 11, Issue 2, 1997, Pages 133-138

  Jost, Stefan ^a,b   Hausmann, Dirk ^a   Lippolt, Peter ^a   Sturm, Matthias ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b Rehabilitations Zentrum J   (Germany)

Author keywords

Beta blockers; Celiprolol; Coronary artery diameter; Coronary stenosis; Coronary vasomotility

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CELIPROLOL; GLYCERYL TRINITRATE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTERY DIAMETER; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY OBSTRUCTION; FEMALE; HEART RATE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LUNG WEDGE PRESSURE; MALE; PRIORITY JOURNAL; SUBLINGUAL DRUG ADMINISTRATION; SYSTOLIC BLOOD PRESSURE; VASOCONSTRICTION; VASODILATATION;

ADRENERGIC BETA-ANTAGONISTS; ADULT; AGED; BLOOD PRESSURE; CELIPROLOL; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CORONARY VESSELS; FEMALE; HEART RATE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; MUSCLE TONUS; MUSCLE, SMOOTH, VASCULAR; NITROGLYCERIN; PULMONARY WEDGE PRESSURE; VASODILATOR AGENTS;

EID: 0030948273     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1007780713915     Document Type: Article

References (32)

1. Robertson RM, Wood AJJ, Vaughn WK, Robertson D. Exacerbation of vasotonic angina pectoris by propranolol. Circulation 1982;65:281-285.
2. Cieslinski G, Hopf R, Kober G, Kaltenbach M. Can β-blockers trigger coronary spasms? Deutsch Med Wochenschr 1987;112:593-596.
3. Tilmant PY, Lablanche JM, Thieuleux FA, Dupuis BA, Bertrand ME. Detrimental effect of propranolol in patients with coronary arterial spasm countered by combination with diltiazem. Am J Cardiol 1983;52:230-233.
4. Vatner S, Hintze THH. Mechanism of constriction of large coronary arteries by β-adrenergic receptor blockade. Circ Res 1983;3:389-400.
5. Rafflenbeul W, Berger C, Lichtlen P. Einfluß von Beta-Rezeptorenblockern auf Koronargefäße. In: Grosdanoff P, Kaindl F, Kraupp O, et al. Beta-Rezeptoren und Beta-Rezeptorenblocker. Berlin: Walter de Gruyter, 1988:179-186.
6. Brown BG, Bolson EL, Dodge HR. Dynamic mechanisms in human coronary stenosis. Circulation 1984;70:917-922.
7. Bortone AS, Hess OM, Gaglione A, et al. Effect of intravenous propranolol on coronary vasomotion at rest and during dynamic exercise in patients with coronary artery disease. Circulation 1990;81:1225-1235.
8. Rafflenbeul W, Berger C, Jost S. Vasoconstriction of epicardial coronary arteries with selective and nonselective β-blockers (abstr). Circulation 1988;78(Suppl II):II36.
9. Marmo E, Filippelli A, Matera C, et al. Celiprolol, a new beta-blocking agent that modulates adrenergic receptors: Experimental in vitro research. Curr Therap Res 1986; 30:475-486.
10. Pruss TP, Khandwala A, Wolf PS, Grebow P, Wong L. Celiprolol: A new beta adrenoceptor antagonist with novel ancillary properties. J Cardiovasc Pharmacol 1986;8(Suppl 4):S29-S32.
11. Taylor SH. Beta-blocking drugs and myocardial function. J Cardiovasc Pharmacol 1986;8(Suppl 4):S75-S82.
12. Frishmen WH, Heimann M, Soberman J, Greenberg S, Eff J, for the Celiprolol International Angina Study Group. Comparison of celiprolol and propranolol in stable angina pectoris. Am J Cardiol 1991;67:665-670.
13. Eff J, Godfrey J, Garutti R, Capone P. Celiprolol in angina pectoris: A controlled study. J Cardiovasc Pharmacol 1986;8(Suppl 4):S132-S134.
14. Frohlich ED. Vasodilatory β-blockers: Systemic and regional hemodynamic effects. Am Heart J 1991;121:1012-1017.
15. Tsukiyama H, Otsuka K, Horii M. Haemodynamic effects of new β-blockers with vasodilatory properties in essential hypertension. Drugs 1988;36:48-54.
16. Jost S, Rafflenbeul W, Gerhardt U, et al. Influence of ionic and non-ionic radiographic contrast media on the vasomotor tone of epicardial coronary arteries. Eur Heart J 1989; 10(Suppl F):60-65.
17. Silke B, Verma SP, Frais MA, Reynolds G, Taylor SH. Comparative effects of metoprolol and celiprolol on cardiac hemodynamics and left ventricular volume at rest and during exercise-induced angina. Clin Pharmacol Ther 1986;39:5-14.
18. Austen WG, Edwards JE, Frye RL, et al. A reporting system on patients evaluated for coronary artery disease: Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association. Circulation 1975;51:5-40.
19. Reiber JHC, Serruys PW, Kooijman CJ, et al. Assessment of short-, medium- and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation 1985;71:280-288.
20. Jost S, Rafflenbeul W, Reil GH, et al. Reproducible uniform coronary vasomotor tone with nitrocompounds: Prerequisite of quantitative coronary angiographic trials. Cathet Cardiovasc Diagn 1990;20:168-173.
21. 2) beta-adrenergic blockade on systemic and coronary hemodynamic findings in angina pectoris. Am J Cardiol 1987; 60: 244-248.
22. Gaglione A, Hess OM, Conn WJ, Ritter M, Grimm J, Krayenbühl HP. Is there coronary vasoconstriction after intracoronary beta-adrenergic blockade in patients with coronary artery disease? J Am Coll Cardiol 1987;10:299-310.
23. Feigl EO. The paradox of adrenergic coronary vasoconstriction. Circulation 1987;76:737-745.
24. Heusch G. Alpha-adrenergic mechanisms in myocardial ischemia. Circulation 1990;81:1-13.
25. Rimele TJ, Rooke TW, Aarhus LL, Vanhoutte PM. Alpha-1 adrenoceptors and calcium in isolated canine coronary arteries. J Pharmacol Exp Ther 1983;226:668-672.
26. Kaski JC, Rodriguez-Plaza L, Brown J, Maseri A. Efficacy of carvedilol (BM 14, 190), a new beta-blocking drug with vasodilating properties in exercise-induced ischemia. Am J Cardiol 1985;56:35-40.
27. Silke B, Verma SP, Frais MA, Reynolds G, Taylor SH. Differential actions of atenolol and celiprolol on cardiac performance in ischemic heart disease. J Cardiovasc Pharmacol 1986;8(Suppl 4):S138-S144.
28. Heublein B, Modersohn D, Franz N, Panzner B. Acute haemodynamic profile of celiprolol in patients with coronary heart disease and hypertension: A double-blind comparison with metoprolol. Eur Heart J 1991;12:617-623.
29. McLenachan JM, Dargie HJ. A review of the clinical experience with celiprolol in angina. Am Heart J 1991;121: 688-690.
30. Modersohn D, Franz N, Heublein B, Panzner B, Walde T, Bruch L. Acute influence of beta-adrenergic antagonists on left ventricular diastolic function: Contrasting results after administration of celiprolol and metoprolol. J Hum Hypertens 1994;8:127-132.
31. Porter TR, Sears T, Xie F, et al. Intravascular ultrasound study of angiographically mildly diseased coronary arteries. J Am Coll Cardiol 1993;22:1858-1865.
32. Yamagishi M, Nissen SE, Booth DC, et al. Coronary reactivity to nitroglycerin: Intravascular ultrasound evidence for the importance of plaque distribution. J Am Coll Cardiol 1995;25:224-230.